Results for: Diabetes

In a bid to make healthcare more accessible, the Indian government has announced significant price reductions for 41 commonly used medicines and six formulations. These revised prices target various conditions, including diabetes, cardiovascular diseases, liver issues, infections, allergies, multivitamins, and antibiotics. This move is expected to benefit millions of patients who rely on these essential medications. The decision was made by the National Pharmaceutical Pricing Authority (NPPA) during its 143rd meeting.

Eli Lilly’s popular obesity and diabetes drugs, Mounjaro and Zepbound, are facing ongoing shortages that are limiting their supply and impacting the company’s earnings. According to analysts, these shortages could result in lower revenue and earnings per share for the first quarter. The company is working to ramp up manufacturing to meet the demand, but the impact on earnings remains a concern. Investors will be watching for updates on manufacturing capacity, pricing, and coverage decisions from insurers as they assess the impact on Lilly’s financial performance.

Emulsifiers, food additives commonly used to enhance the texture and shelf life of ultra-processed foods, have been linked to an increased risk of Type 2 diabetes, according to a recent study published in The Lancet Diabetes & Endocrinology. These additives, such as xantham gum and guar gum, are known to alter the gut microbiota, leading to inflammation and insulin resistance.

Senator Bernie Sanders has opened an investigation into the exorbitant pricing of Novo Nordisk’s diabetes and weight loss drugs, Ozempic and Wegovy. In a letter addressed to the company’s CEO, Sanders expressed his concerns over significant price discrepancies between the medications and across different countries. Despite their shared active ingredient, Ozempic and Wegovy are priced markedly differently, with costs in the United States far exceeding those in Canada and Europe. Sanders cited a Yale University report suggesting that these drugs could be produced profitably for less than $5 per month, raising questions about Novo Nordisk’s pricing strategy.

Donald Payne Jr., a Democrat who served New Jersey in the House for over a decade, has passed away at the age of 65 due to complications from diabetes.

A comprehensive study by the Indian Council of Medical Research reveals a concerning prevalence of non-communicable metabolic diseases in various Indian states. The report, published in The Lancet Diabetes & Endocrinology, highlights the increasing prevalence of diabetes, hypertension, obesity, and dyslipidemia in India. The study’s findings emphasize the need for region-specific strategies to mitigate this growing public health issue.

Sugar Defender is a natural blood sugar supplement that contains clinically proven ingredients to help control blood sugar levels and improve overall health. The supplement is made with non-GMO ingredients and is free of harmful substances. It is also non-habit forming and does not contain any stimulants. Sugar Defender is available in a dropper bottle, making it easy to take daily. The supplement is backed by a 60-day money-back guarantee.

Delhi Minister Atishi has raised concerns over Chief Minister Arvind Kejriwal’s medical care in Tihar Jail, citing a recent court verdict. According to Atishi, the Rouse Avenue Court’s ruling suggests that Kejriwal did not receive adequate medical attention during his 22-day detention. She emphasized the need for a medical board comprised of specialists to monitor Kejriwal’s health due to his severe diabetes.

India has become the ‘diabetic capital’ with an estimated 74 million diabetic patients. Diabetes, a global health crisis, is often undetected due to lack of awareness, leading to serious health complications. It is no longer confined to the elderly population, as it is increasingly affecting youths and children due to unhealthy lifestyles and poor diet. However, managing diabetes is not impossible, and early detection and proper treatment can prevent or reverse the condition.

A study published in the Journal of the Academy of Nutrition and Dietetics investigates the relationship between avocado consumption and diabetes in Mexican adults. The findings suggest that avocado consumption may be associated with a lower risk of diabetes among women, but not among men. Further research is needed to confirm these findings and explore the potential role of avocados in diabetes prevention and management.